Lung Cancer Clinical Trials in Oklahoma, OK

Explore lung cancer clinical trials in Oklahoma, OK, connecting patients to potential novel therapies.

Clinical Research in Oncology

Lung cancer clinical trials are driving progress in oncology by exploring potential treatment options. Therefore, our lung cancer clinical trials in Oklahoma, OK enable physicians to seamlessly integrate these clinical trials into their practices for better patient care.

Advanced Thoracic Tumors

Join Hightower’s clinical trials in Oklahoma City to explore new potential therapies for advanced thoracic tumors. This study focuses on finding the promising treatment by evaluating an investigational drug in combination with other therapies. Additionally, participants will receive expert care throughout the process, with all study-related procedures provided at no cost and no insurance required. By participating, you’ll contribute to vital research to improve outcomes for patients with complex thoracic tumors while potentially benefiting from potential advanced treatments. Therefore, complete the form to connect with our research team and determine your eligibility.

Enroll Now

Age

18 Years to 100 Years 

Gender

All

Condition

Advanced Thoracic Tumor

Current Status

Recruiting

Location

Oklahoma

Study Information

Lung Cancer

Study NameProtocol NumberSponsor
Advanced Thoracic Tumors

20230167

Amgen

Non-Small Cell Lung Cancer

Join advanced non-small cell lung cancer (NSCLC) clinical trials in Oklahoma City to explore potential novel treatments aimed at improving patient outcomes. These trials compare two drug combinations to determine which offers better results for individuals with specific gene mutations, potentially enhancing the immune system’s ability to fight cancer. With the guidance of expert physicians and all study-related procedures provided at no cost, participants receive exceptional care without the need for insurance. Moreover, your participation could help drive progress in lung cancer treatment.

Enroll Now

Age

18 Years and older

Gender

All

Condition

Non-Small Cell Lung Cancer

Current Status

Recruiting

Location

Oklahoma

Study Information

Non-Small Cell Lung Cancer

Study NameProtocol NumberSponsor
Non-Small Cell Lung Cancer

PAC 8 – D9075C00001

AstraZeneca

TRITON – D419ML00003

AstraZeneca